Affini-T Therapeutics

Affini-T Therapeutics is a company that provides cancer immunotherapy using the T cell receptor (TCR). It genetically modifies T cells to recognize tumor cells and inject them into patients. After detecting the tumor cells, the modified T cells generate an immune response against them.